阅读说明：本技术 解酒组合物及其制备方法 (Sobering-up composition and preparation method thereof ) 是由 金忠焕 金旲泫 金成泫 申保燮 于 2020-02-03 设计创作，主要内容包括：本发明涉及一种解酒组合物,更为详细地涉及一种含有锌及中药物质萃取物的解酒组合物及其制备方法。本发明的解酒组合物具有在饮用或摄取后两个小时以内分解大部分酒精的效果,这与以往的解酒产品相比具有明显卓越的效能。(The invention relates to an anti-inebriation composition, in particular to an anti-inebriation composition containing zinc and traditional Chinese medicine extracts and a preparation method thereof. The anti-inebriation composition has the effect of decomposing most of alcohol within two hours after drinking or taking, and has obvious and excellent efficiency compared with the prior anti-inebriation product.)

1. A method for preparing an anti-hangover composition comprises:

a step of solvent-extracting a first mixture comprising hovenia dulcis thunb, glycyrrhiza uralensis, pueraria lobata and pueraria lobata to obtain an extract; and

a step of dissolving a second mixture of a dry powder of the extract, zinc oxide (zinc oxide), and a sugar compound having a structure of the following chemical formula 1 or chemical formula 2, a derivative thereof, or a salt thereof to obtain a zinc-sugar complex solution,

[ chemical formula 1]

[ chemical formula 2]

Wherein, R is₁To R₅And R₇To R₁₀Each independently hydrogen or (C1-C7) alkyl;

the R is₆Is hydrogen, hydroxyl (C1-C7) alkyl or (C1-C7) alkoxy.

2. The method for preparing an anti-hangover composition according to claim 1,

the first mixture comprises, by weight, 1-50 parts of kudzu root, 1-50 parts of flower of kudzu vine and 1-10 parts of licorice root, relative to 100 parts of semen hoveniae.

3. The method for preparing an anti-hangover composition according to claim 1,

the solvent used for solvent extraction is water or C1-C4 lower alcohol.

4. The method for preparing an anti-hangover composition according to claim 3,

and during the solvent extraction, extracting for 1-20 hours at 70-200 ℃.

5. The method for preparing an anti-hangover composition according to claim 1,

the second mixture contains 100 to 500 parts by weight of zinc oxide and 10 to 100 parts by weight of the sugar compound based on 1 part by weight of the dry powder.

6. The method for preparing an anti-hangover composition according to claim 1,

the R is₁To R₅And R₇To R₁₀Each independently hydrogen or (C1-C3) alkyl;

the R is₆Is hydrogen, hydroxyl (C1-C3) alkyl or (C1-C3) alkoxy.

7. The method for preparing an anti-hangover composition according to claim 1,

the R is₁To R₅And R₇To R₁₀Is a hydrogen atom, and is,

the R is₆Is hydrogen, hydroxy or- (CH)₂-OH。

8. The method for preparing an anti-hangover composition according to claim 1,

the compound having the structure of chemical formula 1 or chemical formula 2 is glucose, fructose, or galactose.

9. The method for preparing an anti-hangover composition according to claim 1,

the first mixture further comprises Salvia miltiorrhiza, Ganoderma lucidum or mixtures thereof.

10. The method for preparing an anti-hangover composition according to claim 1,

the second mixture further includes vitamin B1.

11. The method for preparing an anti-hangover composition according to claim 10,

the second mixture and the vitamin B1 are mixed after separate sterilization.

12. An anti-hangover composition comprises the following effective components:

a sugar compound having a structure of the following chemical formula 1 or chemical formula 2, a derivative thereof, or a salt thereof;

zinc oxide (zinc oxide); and

the mixed extract of the hovenia dulcis thunb, the liquorice, the pueraria flower and the pueraria root,

[ chemical formula 1]

[ chemical formula 2]

The R is₁To R₅And R₇To R₁₀Each independently hydrogen or (C1-C7) alkyl;

the R is₆Is hydrogen, hydroxyl (C1-C7) alkyl or (C1-C7) alkoxy.

13. The anti-hangover composition according to claim 12,

the R is₁To R₅And R₇To R₁₀Each independently is hydrogen or (C1-C3) alkaneA group;

the R is₆Is hydrogen, hydroxyl (C1-C3) alkyl or (C1-C3) alkoxy.

14. The anti-hangover composition according to claim 12,

the R is₁To R₅And R₇To R₁₀Is a hydrogen atom, and is,

the R is₆Is hydrogen, hydroxy or- (CH)₂-OH。

15. A health functional beverage containing the antialcoholic composition according to any one of claims 12 to 14.

16. A functional health chocolate comprising the anti-hangover composition according to any one of claims 12 to 14.

17. A pharmaceutical product containing the antialcoholic composition according to any one of claims 12 to 14.

18. A cosmetic containing the antialcoholic composition according to any one of claims 12 to 14.

Technical Field

The invention relates to an anti-inebriation composition, in particular to an anti-inebriation composition containing zinc and traditional Chinese medicine extracts and a preparation method thereof.

Background

Since the 1980 s, due to social turbulence and economic instability, the sales of Chinese liquor in China has increased, and the average daily alcohol consumption of each adult in 1996 is six bottles of beer. This is an alarming problem in terms of national health, and people are concerned about anti-alcohol drugs or beverages due to frequent alcohol abuse in alcohol culture.

When a large amount of alcohol components contained in wine enter the human body, it is difficult to maintain homeostasis due to disruption of metabolic system balance. In particular, in the most severely affected livers, fatty liver and liver cirrhosis and other disorders occur in the long term of drinking, and hangover (hangover) such as thirst, boredom, fatigue, memory loss, dyspepsia, vomiting, diarrhea and vitamin deficiency is suffered in the short term. Thus, not only is normal daily activities difficult, but also the weak activities cause side effects that seriously affect oneself and others.

In order to alleviate hangover as described above, various dosage forms of anti-hangover products have been developed and sold. For example, Korean laid-open patent publication No. 2001-0019767 discloses a natural tea for alleviating hangover and a preparation method thereof, in which pueraria flower, pueraria root, glycyrrhiza, atractylodis macrocephala, citri reticulata, alisma orientale, lycium barbarum and ginger are used. Korean patent publication No. 1534550 discloses an anti-hangover agent comprising sumac wood and a method for preparing the same, and discloses that powder having an increased content of active ingredient of sumac wood is dissolved in water, wine or liquid beverage to be used as a beverage.

As described above, products using various methods have been developed and sold for antialcoholism, but there has been little progress in the development of products having a remarkably excellent antialcoholism effect even in a small amount.

(patent document 1) Korean laid-open patent publication No. 2001-0019767

(patent document 2) Korean patent publication No. 1534550

Disclosure of Invention

The invention aims to provide a preparation method of an anti-inebriation composition, the method mixes hovenia dulcis thunb, kudzuvine root, kudzuvine flower, liquorice, salvia miltiorrhiza, lucid ganoderma extracts, zinc and vitamin B1 according to a specified proportion to prepare the anti-inebriation composition with obviously improved anti-inebriation effect, and the invention also aims to provide the anti-inebriation composition prepared by the method in a form of easy taking.

The preparation method of the anti-alcoholism composition comprises the following steps: a step of solvent-extracting a first mixture comprising hovenia dulcis thunb, pueraria lobata and glycyrrhiza to obtain an extract: and dissolving a second mixture of a dry powder of the extract, zinc oxide (zinc oxide), and a sugar compound having a structure of the following chemical formula 1 or chemical formula 2, a derivative thereof, or a salt thereof to obtain a zinc-sugar complex solution.

[ chemical formula 1]

[ chemical formula 2]

The R is₁To R₅And R₇To R₁₀Each independently hydrogen or (C1-C7) alkyl;

the R is₆Is hydrogen, hydroxyl (C1-C7) alkyl or (C1-C7) alkoxy.

In the method for preparing the anti-hangover composition according to an embodiment of the present invention, the first mixture may include 1 to 50 parts by weight of pueraria lobata, and 1 to 10 parts by weight of glycyrrhiza uralensis, based on 100 parts by weight of hovenia dulcis thunb.

In the method for producing an anti-hangover composition according to an embodiment of the present invention, the solvent used for the solvent extraction may be water or a lower alcohol having (C1-C4) carbon atoms.

In the method for preparing the anti-hangover composition according to an embodiment of the present invention, the solvent extraction may be performed at 70 to 200 ℃ for 1 to 20 hours.

In the method for producing an anti-hangover composition according to an embodiment of the present invention, the second mixture may include 100 to 500 parts by weight of zinc oxide and 10 to 100 parts by weight of the sugar compound with respect to 1 part by weight of the dry powder.

In one embodiment of the present invention, the anti-hangover composition further comprises R₁To R₅And R₇To R₁₀Each independently can be hydrogen or (C1-C3) alkyl; the R is₆Can be hydrogen, hydroxy (C1-C3) alkyl or (C1-C3) alkoxy.

In one embodiment of the present invention, the anti-hangover composition further comprises R₁To R₅And R₇To R₁₀Can be hydrogen, said R₆Can be hydrogen, hydroxy or- (CH)₂-OH。

In the method for preparing the anti-hangover composition according to an embodiment of the present invention, the compound having the structure of chemical formula 1 or chemical formula 2 may be glucose, fructose, or galactose.

In one embodiment of the present invention, the first mixture may further include salvia miltiorrhiza, ganoderma lucidum or a mixture thereof.

In one example of the method for preparing the anti-hangover composition of the present invention, the second mixture may further include vitamin B1.

In the method for producing the anti-hangover composition according to an embodiment of the present invention, the second mixture and vitamin B1 may be separately sterilized and then mixed.

In addition, the effective components of the anti-alcoholism composition of the invention can contain: a sugar compound having a structure of the following chemical formula 1 or chemical formula 2, a derivative thereof, or a salt thereof; zinc oxide (zinc oxide); and mixed extracts of semen Hoveniae, radix Puerariae, flos Puerariae Lobatae and Glycyrrhrizae radix.

[ chemical formula 1]

[ chemical formula 2]

The R is₁To R₅And R₇To R₁₀Each independently hydrogen or (C1-C7) alkyl;

the R is₆Is hydrogen, hydroxyl (C1-C7) alkyl or (C1-C7) alkoxy.

In an anti-hangover composition according to an embodiment of the present invention, R is₁To R₅And R₇To R₁₀Each independently can be hydrogen or (C1-C3) alkyl; the R is₆Can be hydrogen, hydroxy (C1-C3) alkyl or (C1-C3) alkoxy.

In an anti-hangover composition according to an embodiment of the present invention, R is₁To R₅And R₇To R₁₀Can be hydrogen, said R₆Can be hydrogen, hydroxy or- (CH)₂-OH。

In addition, the healthy functional beverage contains the anti-inebriation composition.

In addition, the health functional chocolate contains the anti-alcohol composition.

In addition, the medicine or the pharmaceutical composition contains the anti-inebriation composition.

The cosmetic contains the anti-alcohol composition.

The anti-inebriation composition has the effect of decomposing most of alcohol within two hours after drinking or taking, and has obvious and excellent efficiency compared with the prior anti-inebriation product.

Drawings

Figure 1 shows the results of breath alcohol concentration at different times.

Fig. 2 is the result of the alcohol residual rate in expired air with respect to the initial concentration.

Fig. 3 shows the results of the recovery (%) and the fraction of persons reaching 0% of the anti-hangover composition.

Detailed Description

The anti-hangover composition according to the present invention and the preparation method thereof will be described in detail below with reference to the attached tables or drawings.

This is provided by way of example only, when there are drawings, to ensure that the idea of the invention is fully conveyed to the person skilled in the art. Therefore, the present invention is not limited to the proposed drawings, but may be embodied in other forms, which may be shown enlarged to clarify the idea of the present invention.

At this time, unless otherwise defined, technical and scientific terms used have meanings commonly understood by those skilled in the art to which the present invention belongs, and descriptions of well-known functions and structures, which may make the gist of the present invention unclear, are omitted in the following description and the accompanying drawings.

In addition, the singular forms used in the specification of the present invention may also be intended to include the plural forms unless the context specifically indicates otherwise.

In the description of the present invention, the unit used unless otherwise specified is based on weight, and the unit of% or ratio refers to weight% or a weight ratio, as an example.

In the description of the present invention, the expression "including" is an open-ended expression having a meaning equivalent to the expression "including", "containing", "having" or "characterized by … …", and does not exclude elements, materials or steps not listed further. Further, the phrase "consisting essentially of … …" means that other elements, materials, or steps not listed with the particular element, material, or step may be present to the extent that they do not unacceptably materially affect at least one of the basic and novel technical concepts of the present invention. Further, the expression "consisting of … …" means that only the described elements, materials, or processes are present.

The terms "component", "composition of compounds", "compound", "drug", "pharmaceutically active agent", "cure", "treatment" or "medicament" as used in the description of the present invention are intended to denote a compound or a composition of compounds or substances which, upon administration to a subject (human or animal), causes a desired pharmaceutical and/or physiological effect by local and/or systemic action, which may be used interchangeably.

The terms "treatment" or "treatment" (and also different forms thereof) as used in the description of the invention include prophylactic (e.g. prophylactic treatment), curative or palliative treatment. The term "treating" as used herein includes use to alleviate or reduce at least one adverse or negative effect or symptom of a condition, disease or disorder.

In the present invention, "sample" or "specimen" means an object to be analyzed, and is used as the same meaning throughout the specification.

In the present specification, the term "substituted or unsubstituted" means substituted with one or more substituents selected from deuterium; a halo group; a cyano group; a nitrile group; a nitro group; a hydroxyl group; a carbonyl group; an ester group; an imide group; an amino group; a phosphine oxide group; an alkoxy group; an aryloxy group; an alkylsulfoxy group; arylthio (arylthio group); an alkylsulfoxy group; an aryloxy group; a silyl group; a boron group; an alkyl group; a cycloalkyl group; an alkenyl group; an aryl group; aralkyl group; an aralkenyl group; an alkylaryl group; an alkylamino group; an aralkylamino group; a heteroaryl amino group; an arylamine group; an aryl phosphine group; or a heteroaryl group including at least one of N, O and S atoms, or a substituted or unsubstituted group in which two or more substituents among the above-exemplified substituents are bonded. For example, "a substituent in which two or more substituents are linked" may be a biphenyl group. That is, biphenyl can be aryl, and can also be interpreted as a substituent with two phenyl groups attached.

The term "alkyl group" described in the present specification means a monovalent straight or branched saturated hydrocarbon radical consisting of only carbon and hydrogen atoms, and examples of such an alkyl radical include, but are not limited to, methyl, ethyl, propyl, isopropyl, butyl, isobutyl, tert-butyl, pentyl, hexyl, and the like.

The term "alkoxy" as used herein refers to a monovalent-O-alkyl radical in which oxygen and an alkyl group are bonded, wherein "alkyl" is as defined above. Examples of such alkoxy radicals include, but are not limited to, methoxy, ethoxy, isopropoxy, butoxy, isobutoxy, tert-butoxy, and the like.

The term "aryl" described in the present specification means an organic radical derived by removing one hydrogen from an aromatic hydrocarbon, and includes a monocyclic or condensed ring system containing suitably four to seven ring atoms, preferably five or six ring atoms, in each ring, and also includes a form in which a plurality of aryl groups are connected by a single bond. Specific examples include, but are not limited to, phenyl, naphthyl, biphenyl, and indenyl (indenyl), among others.

The term "heteroaryl" described in the present specification means an aromatic group containing one to four heteroatoms selected from N, O and S as aromatic ring skeleton atoms and the remaining aromatic ring skeleton atoms being carbon. It is a five-to six-membered monocyclic heteroaryl group and a polycyclic heteroaryl group fused with one or more benzene rings, and may be partially saturated. The heteroaryl group in the present invention also includes a form in which one or more heteroaryl groups are bonded by a single bond. Examples of such heteroaryl groups include, but are not limited to, pyrrole, indole, quinoline, isoquinoline, pyridine, pyrimidine, oxazole, thiazole, thiadiazole, triazole, imidazole, benzimidazole, isoxazole, benzisoxazole, thiophene, benzothiophene, furan, benzofuran, and the like. The heteroaryl group may have a carbon atom or a nitrogen atom as a binding site in the ring.

The term "aralkyl" described in the present specification means an alkyl group substituted with an aromatic carbocyclic ring having one, two or three rings, and includes, for example, but not limited to, benzyl and the like.

The term "aryloxy" as used in the present specification means a monovalent radical in which an oxygen and an aryl group are bonded, wherein the "aryl group" is as defined above. Examples of such aryloxy radicals include, but are not limited to, phenoxy, naphthoxy, and the like.

The term "arylalkoxy group" described in the present specification means a monovalent radical in which an alkyl group and an oxygen of an aralkyl group are bonded, wherein "aralkyl group" is as defined above. Examples of such arylalkoxy radicals include, but are not limited to, benzyloxy and the like.

The method for preparing the anti-hangover composition of the present invention is described in detail below.

The preparation method of the anti-alcoholism composition comprises the following steps: a step of solvent-extracting a first mixture comprising hovenia dulcis thunb, pueraria lobata and glycyrrhiza to obtain an extract; and a step of dissolving a second mixture of a dry powder of the extract, zinc oxide (zinc oxide), and a sugar compound having a structure of the following chemical formula 1 or chemical formula 2, a derivative thereof, or a salt thereof, to obtain a zinc-sugar complex solution.

[ chemical formula 1]

[ chemical formula 2]

The R is₁To R₅And R₇To R₁₀Each independently hydrogen or (C1-C7) alkyl;

the R is₆Is hydrogen, hydroxyl (C1-C7) alkyl or (C1-C7) alkoxy.

Hovenia dulcis (Hoveniae Semen Cum Fructs) is a deciduous tree belonging to the family Hippophae, grows in the North Zhongqing and North Qingshang Korea at an altitude of 400m or less, and is known to be distributed in Japan and China mainland. The fruit stem contains sucrose, glucose, fructose, catalase and peroxidase. The total sugar content was about 13% by weight of the total, and the contents of glucose and sucrose were about the same.

Pueraria Radix (Pueraria Radix) represents periderm-removed root part of Pueraria lobata belonging to Leguminosae, and the root contains isoflavone compound daidzein (4' -7-dihydroxyisoflavone) C₁₅H₁₀O₄Daidzin (daidzein-7-glucoside) C₂H₂₀O₉Puerarin (8-C-glucopyranosyl daidzein; 8-C-glucopyranosyl daidzein) C₂₁H₂₀O₉Puerarin xyloside, luteolinBiotin A C₁₆H₁₂O₅(melting point 214-216 ℃ C.) and starch: (10 to 14 wt.%), coumarin, and the like.

Flos Puerariae Lobatae (Pueraria Flos) represents flower part of Pueraria Lobatae belonging to Leguminosae, and is used for quenching thirst, relieving emesis caused by hangover, relieving anorexia or improving intestinal hemorrhage.

Licorice (Glycyrrhiza uralensis Fisher) is a plant belonging to the family Leguminosae (Leguminosae), mainly glycyrrhizin (Glycyrrhiza) and glycyrrhetinic acid (glycyrrhetic acid) belonging to triterpenoid (triterpenoid) system hormones, and contains glycyrrhizin (liquiritigenin), isoliquiritigenin (liquiritin), neoliquiritin (neoliquiritin), etc. belonging to flavonoid (flavonoids) system, glycerestrone (glycofurone), glycyrrhizin (glycopyrrolate), isoliquiritigenol (isocyrol), allicin (lycoridin), 7-acetoxy-2-methylisothioflavone (7-acetoxy-2-methylisoflavonone), etc. belonging to isoflavone (isoflavanoid) system, which has anti-inflammatory, anti-ulcer, anti-inflammatory, analgesic (analgesic) effects, and the like, and is used in antipyretic and analgesic effects.

Salvia miltiorrhiza (Salviae miltiorrhizae Radix) refers to a root of the family Labiatae, the main component of which contains tanshinone (tanshinone) I, tanshinone (II), Salviae IIA, IV), oleoyl neocryptotanshinone (oleoyl neotanshinone), oleoyl danshenxinun (oleoyl danshenxinun), neotanshinone (neotanshinone), dihydrotanshinone (dihydrotanshinone) I, danshenneoquinone (danshenxinun) A, B, neocryptotanshinone (neotanshinone) II, 6, 12-dihydroxyastrol-5, 8,11, 13-tetraen-7-one (6, 12-dihydroxybioga-5, 8,11,13-teraen-7-one), etc., belonging to diterpene (Phenolic compound), and the main component of which contains Alkaloid (Alkaloid) (salvianid) (A, B, salvianoic acid), and the like belonging to Phenolic compound), tanshinone (Alkaloid) (A, B, salvianoic acid, salvianic acid, etc.), and the main component of which contains vanilloid (neotanshinone), neotanshinone (neotanshinone) II, neotanshinone), neotanshinone (neotanshinone) II, neotanshinone, 6, 12-5, 8,11, 13-tetraene-7-one, and the like, and the main component of which belongs to Phenolic compound (, 4' -dihydroxyphenyl) - (2R) -lactam (3- (3',4' -dihydroxyphenyl) - (2R) -lactamide) and the like. Salvia miltiorrhiza is known to have effects in facilitating vasodilation, improvement and treatment of heart disease, liver cell protection, brain cell protection, and anticancer, etc.

Ganoderma lucidum (Ganoderma lucidum genes ex Fr. Karsten) is fruiting body of Polyporaceae (Polyporaceae) and its congeneric species, and its main component is triterpene (triterpene) containing ganoderic acid (ganoderic acid) A-T, ganoderic acid beta, ganoderiol (ganoderiol) F, ganoderic ketone diol (ganoderic acid), ganoderic acid (lucidic acid) A-P, lucidid aldehyde (lucidid) A-S, methyl ganoderic acid (methyl lucidide) F, adenosine lactone (lucidide), methyl ganoderic acid (methyl ganoderic acid) E, F, methyl ganoderic acid (methyl cyanidate) P, Q, L, 26-hydroxy-5 alpha-lanosterone-7, 9(11) (26-hydroxy-5 alpha-7, 9 (11-24-triene-22-dione), and other polysaccharides (ganoderic acid) (GL-5 alpha-7, 9-24-triene-22-dione) (26-hydroxy-5 alpha-7, 9-24-triene-22-dione, etc.), and the polysaccharides (ganoderic acid) (GL-22, 22) belonging to Polyporaceae) Polysaccharide, C, GLIS belonging to Proteoglycan (Proteoglycan), and the like. Ganoderma lucidum is known to have antitumor, LDL cholesterol lowering, and cholesterol synthesis inhibiting effects of ganoderic acid derivatives. Polysaccharide components are also known to have the effects of protecting liver tissues from damage and inhibiting liver fibrosis.

Zinc (Zinc) is an element having an atomic number of 30, which is a typical inorganic substance constituting cells in the human body and controlling physiological functions. Zinc is an important component constituting 300 or more enzymes involved in cell metabolism (Cherasse Y, Urade Y (2017). International Journal of Molecular sciences.18(11): 2334). Zinc is responsible for regulating the synthesis and secretion of insulin, preventing diabetes, and promoting cell synthesis, thereby promoting growth. Zinc is used for enhancing immunity, and interfering generation and activity of various immunocytes such as T lymphocyte, macrophage and leukocyte, and can be used for treating diarrhea, and dermatoses such as acne and eczema. In the absence of zinc, chronic liver disease, chronic kidney disease, sickle cell disease, diabetes, malignancies and other chronic diseases may develop (prasad. a.s. (2003). British Medical journal.326(7386): 409-10). The zinc intake of food and drug administration is 10-20mg per day, while the male intake prescribed by WHO is 30-60mg, and the female intake is 30-45 mg.

Vitamin B₁(thiamin ) is a water-soluble vitamin of formula C₁₂H₁₇N₄The colorless organosulfur compound of OS has a nitrogen-containing hexagonal ring (pyrimidine) and a sulfur-containing pentagonal ring (thiazole) connected to the carbon located at the center via a methylene bridge (methylene bridge). In most tissues, 80% of vitamin B₁Thiamine pyrophosphate (TPP) converted into a coenzyme form functions as a coenzyme, and is involved in energy metabolism mainly in carbohydrate metabolism. In nervous tissues such as brain, vitamin B₁Converted to Thiamine Triphosphate (TTP). The TPP functions as a coenzyme that interferes with enzymes of the pentose phosphate pathway required for the synthesis of DNA and RNA, thereby interfering with the synthesis of nucleic acids.

Due to energy requirement of all cells, vitamin B is essential nutrient for human body₁All organs of the body are affected by vitamin B₁Known diseases caused by Deficiency of (A) are keratosis, Wernike-Korsakoff syndrome, optic neuropathy, radiation disease, etc. (McCandless, David (2010), Thiamine Deficiency and Association clinical disorders, New York, NY: Humana Press, pp.157-159).

According to the results of one embodiment of the present invention, it was confirmed that the alcohol decomposition effect was exhibited in a significantly accelerated time when the anti-hangover effect was evaluated after mixing the components according to the ratio of the preparation method of the present invention, as compared with the case of using the extracts of the traditional Chinese medicine materials, the zinc component, or the like, respectively. The present inventors believe that this is because when the extract of the above-mentioned Chinese medicinal materials and zinc components are mixed and prepared by the preparation method of the present invention, synergistic effects are produced in the decomposition of alcohol components, although the reason is not clear.

As the acceptable salt of the sugar compound of the present invention, preferably, an addition salt formed from an inorganic acid, for example, hydrochloride, sulfate, phosphate, hydrobromide, hydroiodide, is mentionedNitrates, pyrosulfates, metaphosphates, and the like; addition salts formed with organic acids such as citrate, oxalate, benzoate, acetate, trifluoroacetate, propionate, succinate, fumarate, lactate, maleate, tartrate, glutarate, methanesulfonate, toluenesulfonate, sulfonate and the like; or metal salts such as lithium, sodium, potassium, magnesium, calcium salts, and the like, but not limited thereto.

In the preparation method of the anti-hangover composition according to an embodiment of the present invention, the first mixture includes 1 to 50 parts by weight of pueraria lobata, 1 to 50 parts by weight of pueraria lobata and 1 to 10 parts by weight of licorice with respect to 100 parts by weight of hovenia dulcis thunb, preferably includes 5 to 40 parts by weight of pueraria lobata, 5 to 40 parts by weight of pueraria lobata and 1 to 8 parts by weight of licorice with respect to 100 parts by weight of hovenia dulcis thunb, and more preferably includes 10 to 35 parts by weight of pueraria lobata, 10 to 35 parts by weight of pueraria lobata and 1 to 6 parts by weight of licorice with respect to 100 parts by weight of hovenia dulcis thunb, but the scope of the present invention is not limited thereto. Within the above range, the synergistic effect of significantly improving the alcohol decomposition rate of the anti-hangover composition of the present invention can be obtained, and therefore, the preferred range is.

In the method for producing the anti-hangover composition according to an embodiment of the present invention, the solvent used for the solvent extraction may be water or a lower alcohol having (C1 to C4) carbon atoms, and water may be preferably used, but is not limited thereto. When water or purified water is used, the loss of the effective components of the respective herbal ingredients during extraction is small, and the composition does not contain additional alcohol components, and thus is preferable.

In the preparation method of the hangover alleviating composition according to an embodiment of the present invention, when the solvent is extracted, in one embodiment, the extraction temperature and the extraction time may be 70 to 200 ℃ and 1 to 20 hours, respectively, preferably 80 to 170 ℃ and 2 to 15 hours, and more preferably 90 to 140 ℃ and 3 to 10 hours, but not limited thereto. Within the above range, the content of the active ingredient contained in the anti-hangover composition of the present invention is increased, and therefore, is preferable.

In the method for preparing the anti-hangover composition according to an embodiment of the present invention, the second mixture may include 100 to 500 parts by weight of zinc oxide and 10 to 100 parts by weight of the sugar compound with respect to 1 part by weight of the dry powder, preferably 150 to 450 parts by weight of zinc oxide and 20 to 85 parts by weight of the sugar compound with respect to 1 part by weight of the dry powder, and more preferably 200 to 400 parts by weight of zinc oxide and 30 to 70 parts by weight of the sugar compound with respect to 1 part by weight of the dry powder, but the invention is not limited thereto. Within the above range, the synergistic effect of significantly improving the alcohol decomposition rate of the anti-hangover composition of the present invention can be obtained, and therefore, the preferred range is.

In one embodiment of the present invention, the anti-hangover composition further comprises R₁To R₅And R₇To R₁₀Each independently can be hydrogen or (C1-C3) alkyl; the R is₆Can be hydrogen, hydroxy (C1-C3) alkyl or (C1-C3) alkoxy. Within the above range, the synergistic effect of significantly improving the alcohol decomposition rate of the anti-hangover composition of the present invention can be obtained, and therefore, the preferred range is.

In one embodiment of the present invention, the anti-hangover composition further comprises R₁To R₅And R₇To R₁₀Can be hydrogen, said R₆Can be hydrogen, hydroxy or- (CH)₂-OH. Within the above range, the synergistic effect of significantly improving the alcohol decomposition rate of the anti-hangover composition of the present invention can be obtained, and therefore, the preferred range is.

In the method for preparing the anti-hangover composition according to an embodiment of the present invention, the compound having the structure of chemical formula 1 or chemical formula 2 may be glucose, fructose, or galactose, and the compound may be in the form of the following chemical formula, but is not limited thereto.

(D-glucose)

(D-fructose)

(D-galactose)

Within the above range, the synergistic effect of significantly improving the alcohol decomposition rate of the anti-hangover composition of the present invention can be obtained, and therefore, the preferred range is.

In one embodiment of the present invention, the first mixture may further include salvia miltiorrhiza, ganoderma lucidum or a mixture thereof.

For the salvia miltiorrhiza or the ganoderma lucidum, 1 to 50 parts by weight of the salvia miltiorrhiza and 1 to 10 parts by weight of the ganoderma lucidum can be further included relative to 100 parts by weight of the hovenia dulcis thunb, preferably 5 to 40 parts by weight of the salvia miltiorrhiza and 1 to 8 parts by weight of the ganoderma lucidum can be included relative to 100 parts by weight of the hovenia dulcis thunb, more preferably 10 to 30 parts by weight of the salvia miltiorrhiza and 1 to 6 parts by weight of the ganoderma lucidum can be included relative to 100 parts by weight of the hovenia dulcis thunb, but the scope of the invention is not limited thereto. Within the above range, the synergistic effect of significantly improving the alcohol decomposition rate of the anti-hangover composition of the present invention can be obtained, and therefore, the preferred range is.

In one embodiment of the present invention, the second mixture may further include vitamin B₁。

The vitamin B can be further included by 1-100 parts by weight relative to 1 part by weight of the dry powder₁Preferably, the vitamin B may be included in an amount of 10 to 80 parts by weight₁More preferably, the vitamin B may be included in an amount of 20 to 60 parts by weight₁The scope of the invention is not limited thereto. Within the range, the hangover alleviating group of the present invention can be obtainedThe compound is preferable because of its synergistic effect of significantly increasing the alcohol decomposition rate.

In the method for producing the anti-hangover composition according to an embodiment of the present invention, the second mixture and vitamin B₁Can be mixed after separately sterilizing.

In one example, the sterilization may be performed at 70 to 150 ℃ for 0.1 to 10 minutes, preferably at 75 to 130 ℃ for 0.1 to 5 minutes, and more preferably at 80 to 100 ℃ for 0.1 to 2 minutes, but the scope of the present invention is not limited thereto, and the second mixture and vitamin B can be minimized within the range₁The deformation or loss of the component is preferable because the synergistic effect of the alcohol decomposition rate of the anti-hangover composition of the present invention is significantly improved.

The anti-hangover composition of the present invention will be described in detail below.

The effective components of the anti-alcoholism composition of the invention comprise: a sugar compound having a structure of the following chemical formula 1 or chemical formula 2, a derivative thereof, or a salt thereof; zinc oxide (zinc oxide); and mixed extracts of semen Hoveniae, Glycyrrhrizae radix, flos Puerariae Lobatae and radix Puerariae.

[ chemical formula 1]

[ chemical formula 2]

The R is₁To R₅And R₇To R₁₀Each independently hydrogen or (C1-C7) alkyl;

the R is₆Is hydrogen, hydroxyl (C1-C7) alkyl or (C1-C7) alkoxy.

In an anti-hangover composition according to an embodiment of the present invention, R is₁To R₅And R₇To R₁₀Each independently can be hydrogen or (C1-C3) alkyl; the R is₆Can be hydrogen, hydroxy (C1-C3) alkyl or (C1-C3) alkoxy.

In an anti-hangover composition according to an embodiment of the present invention, R is₁To R₅And R₇To R₁₀Can be hydrogen, said R₆Can be hydrogen, hydroxy or- (CH)₂-OH。

Said R of the invention₁And R₆And R₇And R₁₁The ring may be formed by connecting to each other according to circumstances, but is not limited thereto.

Hereinafter, a health functional food, a pharmaceutical or pharmaceutical composition and a cosmetic using the anti-hangover composition of the present invention will be described in detail.

The health functional beverage contains the anti-inebriation composition.

The chocolate with the health function contains the anti-alcohol composition.

In the present invention, "health functional food" refers to a natural product or a processed product containing one or more nutrients. Preferably, it is a food group that imparts added value to food by using physical, biochemical or bioengineering techniques or the like so that the food functions and expresses functions for specific purposes, or a food that is designed and processed so that the in vivo regulatory functions possessed by the food components and related to the regulation of the rhythm of defense in the living body, the prevention and recovery of diseases, and the like are sufficiently expressed to the living body. The health functional food comprises food acceptable food auxiliary additives, and further comprises suitable carriers, excipients and diluents commonly used in the preparation of health functional foods.

Examples of the functional health foods to which the active ingredient of the present invention can be added include various foods, beverages, chewing gums, teas, vitamin complexes, and the like. Further, special nutritional foods (e.g., formula milk, infant food, etc.), health supplements, candies (e.g., snacks), dairy products (e.g., fermented milk, cheese, etc.), other processed foods, beverages (e.g., fruits, vegetable beverages, soybean milk, fermented beverages, etc.), etc., are included, but not limited thereto. The above food, beverage or food additive can be prepared by conventional preparation method.

The health functional food of the present invention comprises various nutrients, vitamins, minerals (electrolytes), synthetic flavors andflavoring agent such as natural flavoring agent, coloring agent, and flavoring agent(cheese, chocolate, etc.), pectic acid and its salt, alginic acid and its salt, organic acid, protective colloid thickener, pH regulator, stabilizer, preservative, glycerin, water, carbonating agent used for carbonated beverage, etc. These components may be used alone or in combination.

As described above, the health functional food of the present invention may have various dosage forms, particularly, any dosage form of powder, granule, tablet, capsule, beverage, and the like, but is not limited thereto.

The medicine or the pharmaceutical composition contains the anti-inebriation composition. The pharmaceutical composition is formulated into a formulation conventional in the pharmaceutical field by adding conventional pharmaceutically acceptable non-toxic carriers and excipients and the like to the active ingredient. Such formulations are, for example, oral formulations such as tablets, pills, hard and soft capsules, liquids, suspensions, emulsifiers, syrups, granules or elixirs (elixirs); or a sterile aqueous or oily solvent for intravenous, subcutaneous, sublingual, intramuscular administration.

The pharmaceutically acceptable carrier that can be used in the pharmaceutical composition of the present invention is a carrier generally used in formulation, and includes, but is not limited to, lactose, dextrose, sucrose, sorbitol, mannitol, starch, acacia gum, calcium phosphate, alginate, gelatin, calcium silicate, microcrystalline cellulose, polyvinylpyrrolidone, cellulose, water, syrup, Methyl cellulose, Methyl hydroxybenzoate (Methyl hydroxybenzoate), Propyl hydroxybenzoate (Propyl hydroxybenzoate), talc, magnesium stearate, mineral oil, and the like.

Excipients which may be used in the pharmaceutical compositions of the present invention include sweetening agents, binding agents, solubilizing agents, dissolution aids, wetting agents, emulsifying agents, isotonicity agents, adsorbents, disintegrants, antioxidants, preservatives, suspending agents, fillers, flavoring agents and the like, and the proportions and properties of such excipients may be determined by the solubility and chemical characteristics of the selected tablet, the chosen route of administration and standard pharmaceutical practice. Examples of excipients include lactose, dextrose, sucrose, mannitol, sorbitol, cellulose, glycine, silicon dioxide, talc, stearic acid, sterols, magnesium stearate, magnesium aluminum silicate, starch, gelatin, tragacanth, arginine, sodium alginate, methylcellulose, sodium carboxymethylcellulose, agar, water, ethanol, polyethylene glycol, polyvinylpyrrolidone, sodium chloride, calcium chloride, citrus essence, strawberry essence, vanilla flavor, and the like.

In addition, the pharmaceutical composition of the present invention may be formulated into a parenteral administration form, in which case intravenous administration, intraperitoneal administration, intramuscular administration, subcutaneous administration, topical administration, or the like may be employed, but is not limited thereto. In this case, for the preparation into a dosage form for parenteral administration, the pharmaceutical composition may be prepared as a solution or suspension by mixing the active ingredient with a stabilizer or a buffer in water, and this solution or suspension may be prepared as a unit administration form of ampoule (Ampule) or Vial (visual).

In addition, the pharmaceutical composition of the present invention may be sterilized, or further include adjuvants such as preservatives, stabilizers, wettable powdersOr an emulsification promoter, a salt and/or a buffer for adjusting osmotic pressure, and the like, and may further include other substances for assisting the treatment, and may be formulated by a conventional method such as mixing, granulation, or coating.

In addition, the amount of the active ingredient administered to mammals including humans in the pharmaceutical composition of the present invention may vary depending on the age, body weight, sex, administration form, health state and disease degree of the patient. The pharmaceutical composition can be contained in an effective amount of from 0.001 to 500 mg/kg per day, preferably from 0.01 to 100 mg/kg per day, and such pharmaceutical composition can be administered orally or parenterally in divided amounts of once or more than twice a day. However, the amount to be administered may be increased or decreased depending on the administration route, severity of disease, sex, body weight, age, and the like, and thus the amount to be administered is not limited to the present invention in any way.

The cosmetic contains the anti-alcohol composition.

In the present invention, the cosmetic may be any one selected from the group consisting of a solution, a suspension, an emulsion, a paste, a gel, a cream, an emulsion, a powder, a soap, an oil, a foundation, an emulsion foundation, a wax foundation, and a spray, although not limited thereto.

The cosmetic may further comprise, in addition to the active ingredient, ingredients generally used in cosmetics, for example, conventional adjuvants such as antioxidants, stabilizers, solubilizers, vitamins, pigments, and perfumes, and carriers.

In addition, the cosmetic may be prepared in any form commonly prepared in the art, for example, in the form of a solution, a suspension, an emulsion, a paste, a gel, a cream, an emulsion, a powder, a soap, a surfactant-containing cleanser, an oil, a powder foundation, an emulsion foundation, a wax foundation, a spray, etc., but is not necessarily limited thereto. More specifically, it can be made into elastic lotion, astringent lotion, nourishing cream, massage cream, essence, and facial maskSpray or powder.

When the cosmetic is in the form of paste, cream or gel, animal oil, vegetable oil, wax, paraffin, starch, tragacanth, cellulose derivative, polyethylene glycol, silicone, bentonite, silica, talc or zinc oxide can be used as a carrier component.

In addition, when the cosmetic of the present invention is in the form of powder or spray, lactose, talc, silica, aluminum hydroxide, calcium silicate or polyamide powder may be used as a carrier component, and particularly when the cosmetic is in the form of spray, a propellant such as chlorofluorocarbon, propane/butane or dimethyl ether may be further included.

In addition, when the formulation of the cosmetic of the present invention is a solution or emulsion, a solvent, a solubilizer or an emulsifier can be used as a carrier ingredient, and for example, water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, propylene glycol, 1, 3-butylene glycol oil, glycerol aliphatic ester, polyethylene glycol or fatty acid ester of sorbitan can be used.

In addition, when the formulation of the cosmetic of the present invention is a suspension, a liquid diluent such as water, ethanol or propylene glycol; suspending agents such as ethoxylated isostearyl alcohols, polyoxyethylene sorbitol esters and polyoxyethylene sorbitan esters; microcrystalline cellulose, methyl aluminum hydroxide, bentonite, agar-agar, or tragacanth can be used as a carrier component.

The present invention will be described in more detail with reference to examples. The examples are provided to illustrate the present invention more specifically, and the scope of the present invention is not limited thereto.

[ test materials, reagents, and apparatus ]

Hovenia dulcis thunb, kudzuvine root, kudzuvine flower, salvia miltiorrhiza, liquorice, lucid ganoderma, honey, white sugar and the like are purchased from the traditional market.

Zinc oxide, fructose, vitamin B₁Reagents and materials were purchased from Sigma-Merck (Sigma, Merck).

Other measuring devices are purchased for use in korea.

EXAMPLE 1 preparation of anti-hangover composition

Cleaning semen Hoveniae (3.5kg), radix Puerariae (0.8kg), flos Puerariae Lobatae (0.7kg), Saviae Miltiorrhizae radix (0.5kg), Glycyrrhrizae radix (0.1kg) and Ganoderma (0.1kg), adding purified water 150L, extracting at 100 deg.C for four hours, and concentrating under reduced pressure by vacuum concentrator to obtain powder extract 12.6 g.

Thereafter, 4.2g of the powder was dissolved in 10L of purified water together with zinc oxide (1500g), honey (100g), white sugar (50g) and fructose (200g) to obtain a dosage of 100 times.

The resulting mixture was filtered and passed through a high temperature flash sterilizer for 30 seconds at 95 ℃. Separately filtering vitamin B₁(150g) And (5) performing sterilization treatment. After the materials are filled in a container, the antialcoholic composition is prepared by encapsulation.

[ test example 1] evaluation of hangover alleviation

For 18 healthy men and women of 20 years old who were randomly selected, they were allowed to take 180ml of a general-purpose distilled liquor with an alcohol concentration of 18%, and after 30 minutes, they were allowed to take 120ml of the anti-inebriation composition prepared in example 1.

The breath alcohol concentration was measured four hours from the time point at which 30 minutes passed after ingestion.

The blank test group took 120ml of water after drinking, and the control group took a single dose of CJ Kendexing The breath alcohol concentration was measured four hours after the lapse of 30 minutes.

The results are shown in fig. 1 and 2.

From the results, it is understood that the anti-hangover beverage of the present invention almost decomposes alcohol components at the beginning of two hours after drinking, and shows an excellent effect of completely recovering the hangover phenomenon to an effect of almost failing to detect alcohol components. In particular, when the composition of the present invention is taken, the disappearance rate of the alcohol concentration is two times or more faster than that when kendir is taken, and thus the composition of the present invention is found to have an excellent antialcoholic effect.

After the four hour trial was completed, the experimental group was allowed to get up the next day at six am and the nighttime hangover relief was measured.

As a result, most experimental groups showed relief of general hangover-related symptoms, i.e., headache, drowsiness, inattention, hypomnesis, anorexia, etc., and elimination of hangover, compared to the lapse of four hours after the ingestion, thereby confirming that hangover was improved as a whole. Particularly, the composition has obviously excellent recovery effect on dizziness, nausea, bellyache, diarrhea and nervousness symptoms compared with a blank test group and a control group, and has more remarkable effect on the stabilization of the digestive system.

Formulation example 1 preparation of beverage formulation

After 80mg of the anti-hangover composition prepared in example 1, 9mg of vitamin E, 9mg of vitamin C, 0.6g of citric acid, and 25g of liquid oligosaccharide were mixed, 300mL of purified water was added, 200mL of each bottle was filled, and then, sterilization was performed at 130 ℃ for three seconds to prepare an anti-hangover beverage.

Formulation example 2 preparation into chocolate formulation

An anti-hangover chocolate was prepared by a conventional method using 5g of the anti-hangover composition prepared in example 1, 34.5g of white sugar, 34g of cocoa butter, 15g of cacao mass, 15g of cocoa powder, 0.5g of lecithin, and 0.5g of vanilla flavor.